Bionomics PE Ratio 2022-2024 | NEUP
Current and historical p/e ratio for Bionomics (NEUP) from 2022 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Bionomics PE ratio as of December 26, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Bionomics PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2024-12-26 |
4.45 |
|
inf |
| 2024-09-30 |
0.44 |
0 |
0.00 |
| 2023-12-31 |
1.48 |
0 |
0.00 |
| 2023-09-30 |
2.70 |
0 |
0.00 |
| 2023-06-30 |
2.20 |
0 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.010B |
$0.000B |
|
Bionomics Limited is a clinical-stage biopharmaceutical developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system disorders. Bionomics Limited is based in ADELAIDE, Australia.
|
